Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Med Decis Making. 2013 Nov 18;34(4):430–442. doi: 10.1177/0272989X13511705

Table 1.

Description of six likelihood formats – In each case (except Consumer Medication Information (CMI)), a table similar to that in Figure 1 was provided. Differences from Figure 1 are noted under the format description

Format type Format Format description
Non-numeric CMI-like list (CMI) Instead of the table, the CMI list included this text: “Possible Side Effects: dry mouth, constipation, headache, stomach upset, or dizziness. This medicine may very rarely cause muscle damage that can lead to a very serious condition called rhabdomyolysis.”
No numeric information was provided.
Non-numeric Risk-label only The table included Risk labels for likelihoods of all AEs (e.g., very common, rare).
No numeric information was provided.
Numeric Percent only The table included Percentages in place of frequencies (e.g., 14%, 0.05%).
No risk labels were provided.
Numeric Frequency only The table included frequencies (e.g., 14,000, 50 – out of 100,000 people).
No risk labels were provided.
Numeric Percent+Risk label The table included risk labels and included
Percentages instead of frequencies.
Numeric Frequency+Risk label This is Figure 1. Risk labels and frequencies were provided.